GlassScriptPhysician profile
Irina Asher
NPI 1174920391
$1,350.02
in general payments reported to CMS, 2019-2025
12 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $179 · 2024: $740 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250 · Education: $99.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.08 |
| Education | $99.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $548.89 | 2023-2025 | Wakix |
| Pfizer INC. | $315.90 | 2023-2025 | |
| Abbvie INC. | $237.77 | 2023-2025 | |
| Lundbeck LLC | $46.44 | 2024-2025 | Vyepti |
| Scilex Pharmaceuticals INC. | $39.99 | 2024 | |
| Neurocrine Biosciences, INC. | $37.64 | 2025 | |
| Eisai INC. | $24.94 | 2024 | |
| Xeris Pharmaceuticals, INC. | $22.71 | 2024 | Keveyis |
| Amgen INC. | $21.60 | 2024 | Uplizna |
| Jazz Pharmaceuticals INC. | $19.91 | 2025 | |
| Idorsia Pharmaceuticals US INC | $18.71 | 2024 | Quviviq |
| Axsome Therapeutics, INC. | $15.52 | 2025 | Symbravo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Asher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.